Search

Displaying results 8041 - 8050 of 8695 in total
  1. Drug

    Harmine

    go.drugbank.com/drugs/DB07919
    Investigational

    Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
  2. Drug

    AG0301-COVID19

    go.drugbank.com/drugs/DB15856
    Investigational

    The candidate is a plasmid DNA vaccine developed using an intradermal gene transfer method targeting the SARS-CoV-2 spike protein.

  3. Drug

    Tyramine

    go.drugbank.com/drugs/DB08841
    InvestigationalNutraceutical

    An important characteristic of this product is its impediment to cross the blood-brain barrier which restrains its side effects to only nonpsychoactive peripheral sympathomimetic effects.

  4. Drug

    Bufylline

    go.drugbank.com/drugs/DB13812
    Experimental

    Categories: Drugs for Obstructive Airway Diseases, Cytochrome P-450 Substrates
  5. Drug

    Nandrolone

    go.drugbank.com/drugs/DB13169
    Investigational

    Nandrolone, also known as 19-nortestosterone or 19-norandrostenolone, is a synthetic anabolic-androgenic steroid (AAS) derived from testosterone.

    Categories: Anabolic Agents for Systemic Use
  6. Drug

    IMM101

    go.drugbank.com/drugs/DB15851
    Experimental

    It has shown to be safe and well tolerated to complement conventional cancer therapy for patients with melanoma and pancreatic ductal adenocarcinoma [PMID: 21930686; PMID: 30107850; PMID: 27599039].

  7. Drug

    Fenethylline

    go.drugbank.com/drugs/DB01482
    Experimental

    Categories: Psychostimulants, Agents Used for ADHD and Nootropics, Cytochrome P-450 Substrates
  8. Drug

    Incadronic acid

    go.drugbank.com/drugs/DB06255
    Experimental

    Incadronate, or YM-175, is a nitrogen containing bisphosphonate. Along with being investigated to treat hypercalcemia of malignancy, it has also been investigated in the treatment of myeloma, leukemia, and other cancers. Incadronic acid ...

  9. Drug

    JNJ-55308942

    go.drugbank.com/drugs/DB19110
    Investigational

    JNJ-55308942 is under investigation in clinical trial NCT05328297 (A Study of JNJ-55308942 in the Treatment of Bipolar Depression).

    Categories: Purinergic P2 Receptor Antagonists, Purinergic P2X Receptor Antagonists
  10. Drug

    Linopirdine

    go.drugbank.com/drugs/DB13806
    Experimental

    Categories: Psychostimulants, Agents Used for ADHD and Nootropics